☆
Watchlist
Log in
Sign-up
Tali Digital Ltd (td1) Logo

Tali Digital Ltd (TD1)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials (10-yr)

TD1 Chart

Snapshot

TD1's Principal Activity is the delivering diagnostic and therapeutic solutions for cognitive function and behaviour. The Company has built a platform technology, the first iteration of which targets cognitive attention skills during early childhood through its breakthrough evidence a video gamed-based TALi screening (DETECT) and training (TRAIN).

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -79.84%
vs ASX 200 (1yr) -83.55%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,139 of 2,413
Sector Rank 189 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies EPN / ESE / ALT
EPS -$0.006
DPS $0.00
Book Value Per Share $0.01

Broker Consensus

TD1 is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Date Heading Pages File Size Time

Corporate Overview

TALI Digital Limited (TD1, formerly Novita Healthcare Limited) is a digital health company delivering diagnostic and therapeutic solutions to enhance cognitive function and behaviour. TALi platform is a scientific and clinically validated program that addresses the early childhood issue - inattention, a key feature in conditions including Attention deficit hyperactivity disorder (ADHD) and Autism Spectrum Disorder (ASD).

Incorporation Details

Incorporated Avexa was incorporated as a public company on 7 April 2004.

Corporate Details

Head Office Camberwell VIC 3124
Website www.talidigital.com
Registry Automic Group
Auditor Grant Thornton Audit Pty Ltd
Date Listed 23 Sep 2004

Upcoming Calendar (Forecasted)

No calendar entries available.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.
Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Dr Mary Elizabeth Brinson Chief Medical Officer,Chief Executive Officer Apr 2022
Dr David Williams Non-Executive Director Dec 2021

Dr David Williams

Non-Executive Director

Dr Williams has international and domestic healthcare sector experience including 25 years with Cochlear Limited. He held a number of senior commercial and financial roles with the medical devices leader including as Senior Vice President of Finance & Operations for Cochlear Americas, President of Cochlear Americas (acting) and General Manager, Acoustics. Most recently he was Cochlear's Vice President of Global Customer Experience.
Dr David Lionel Brookes Non-Executive Director Jun 2020

Dr David Lionel Brookes

Non-Executive Director

Dr Brookes has experience in the health and biotechnology industries. He was the Non-Executive Chairman of the unlisted Better Medical Group until that company was acquired by private equity firm Livingbridge in January 2021.

Mr Stephen (Steve) Denaro Company Secretary Feb 2019
Ms Sue MacLeman Non-Executive Chairman,Non-Executive Director Sep 2018

Ms Sue MacLeman

Non-Executive Chairman,Non-Executive Director

Ms MacLeman has over 30 years experience in the medtech, pharma and biotech sector and is currently the Chair of MTPConnect (Medical Technology and Pharmaceuticals Industry Innovation Growth Centre MTPII-GC Ltd), Non-Executive Director of Planet Innovation Holdings Ltd and Non-Executive Director of Omico.

Mr Jefferson Harcourt Non-Executive Director Feb 2016

Mr Jefferson Harcourt

Non-Executive Director

Mr Harcourt sits on a number of private technology company boards in the medical device and security markets.

Mary Elizabeth Brinson Chief Medical Officer,Chief Executive Officer N/A
Show All

Director Transactions

TD1 directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
19/04/22 David Brookes Issued 542,858 $0.011 $5,971 Rights issue
19/04/22 David Brookes Issued 28,572 $0.011 $314 Rights issue
19/04/22 Jefferson Harcourt Issued 4,415,642 $0.011 $48,572 Rights issue
19/04/22 Sue MacLeman Issued 115,573 $0.011 $1,271 Rights issue
21/09/21 David Brookes Buy +1,000,000 $0.031 $31,000 On-market trade
09/09/21 Sue MacLeman Buy +303,100 $0.033 $10,128 On-market trade
07/09/21 Glenn Smith Buy +345,454 $0.034 $11,745 On-market trade
02/09/21 Jefferson Harcourt Buy +1,150,000 $0.035 $40,136 On-market trade
27/11/20 David Brookes Issued 3,400,000 $0.038 $129,200 Issue of securities
27/11/20 Glenn Smith Issued 22,500,000 $0.038 $855,000 Issue of securities
22/09/20 Glenn Smith Cancelled 14,377,766 $0.026 $373,821 Cancellation of securities
26/03/20 Sue MacLeman Buy +80,008 $0.022 $1,759 On-market trade
02/12/19 Glenn Smith Cancelled 14,377,766 $0.055 $790,777 Cancellation of securities
02/12/19 Glenn Smith Issued 14,377,766 $0.055 $790,777 Issue of options
28/08/19 Jefferson Harcourt Issued 10,000,000 $0.01 $100,000 Rights issue
28/08/19 Sue MacLeman Issued 133,098 $0.01 $1,331 Rights issue
28/08/19 Mark Simari Issued 454,546 $0.01 $4,545 Rights issue
28/08/19 Glenn Smith Issued 454,546 $0.01 $4,545 Rights issue
28/08/19 Mark Simari Issued 909,091 $0.01 $9,091 Rights issue
19/06/19 Glenn Smith Buy +479,790 $0.018 $8,717 On-market trade
Show All

Director Interests

The current holdings of TD1 directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Jefferson Harcourt 19/04/2022 N/A 44,254,065 3,400,000 N/A
David Brookes 19/04/2022 228,572 4,342,858 3,400,000 N/A
Sue MacLeman 19/04/2022 0 924,593 6,800,000 N/A
David Williams 15/12/2021 0 N/A N/A N/A
Show All

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 25, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 66,494,118 7.14%
Grey Innovation Holdings Pty Ltd 30,909,488 3.32%
Sailors Of Samui Pty Ltd 24,305,455 2.61%
Mondo Electronics Pty Ltd <Mondo Electronics S/F A/C> 19,884,346 2.13%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <DRP A/C> 17,701,984 1.90%
Moonah Capital Pty Ltd 16,000,000 1.72%
JP Morgan Nominees Australia Pty Limited 15,425,505 1.66%
Kembla No 20 Pty Ltd <Caa A/C> 14,300,000 1.53%
Sanlam Private Wealth Pty Ltd <Westbourne Long Short A/C> 12,500,000 1.34%
HSBC Custody Nominees (Australia) Limited 10,222,898 1.10%
Mr Donal Francis O'Sullivan 10,000,000 1.07%
Puntero Pty Ltd 10,000,000 1.07%
Ten Goals Pty Ltd <Hamish Mclachlan Family A/C> 10,000,000 1.07%
Mrs Shweta Priyadarshini 9,850,000 1.06%
Enjiru Pty Ltd <Enjiru Family A/C> 9,044,204 0.97%
CPO Superannuation Fund Pty Ltd <C & P O'Connor S/F A/C> 7,954,271 0.85%
Mr Carmelo Cannavo 7,320,000 0.79%
Peterlyn Pty Ltd <Rpc Salmon Super Fund A/C> 7,200,000 0.77%
Mr Alan Conigrave 7,200,000 0.77%
Teefish Super Pty Ltd <Teefish Super Fund A/C> 7,100,000 0.76%
Jmt Investment Group Vic Pty Ltd 7,000,000 0.75%
Citos Super Pty Ltd <Citos Pty Ltd Sf A/C> 7,000,000 0.75%
Citicorp Nominees Pty Limited 6,881,979 0.74%
Corwest Pty Ltd 6,415,560 0.69%
Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 375 212 200 1,140 797 2,724

Substantial Shareholders

No Substantial Shareholders for TD1 in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
01-08-21 BCCL Worldwide Inc 14,628,760 8.45 6.89
07-07-21 BCCL Worldwide Inc 2,999,251 9.84 8.45

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.031 30 June
2020 $0.025 30 June
TD1 Historical Price Data (CSV)
Up to 20 years of EOD share price history
Sign up to Download
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.